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ABSTRACT
Background: Deletions in the b-globin cluster causing
thalassaemia and hereditary persistence of fetal haemo-
globin (HPFH) are uncommon and difficult to detect. Data
in Chinese are very scarce.
Aims: To use a recently available technique to investigate
the frequencies and nature of b-globin cluster deletions in
Chinese.
Methods: 106 subjects with phenotypes of thalassaemia
or HPFH and suspected to have deletions in the b-globin
cluster were studied. A commercially available kit
employing multiplex ligation-dependent probe amplifica-
tion (MLPA) was used to screen for deletions. Gap PCR
and direct nucleotide sequencing were used to char-
acterise deletions detected.
Results: 17 deletions in the b-globin cluster were found
in 17 patients: 8 of Chinese (Acdb)0 thalassaemia, 7 of
Southeast Asian (Vietnamese) deletion and 2 of Thai
(Acdb)0 thalassaemia. The only type of deletion detected
in db-thalassaemia was Chinese (Acdb)0 thalassaemia.
The deletional form of HPFH was rarely seen in only 1
case of Thai (Acdb)0 thalassaemia. Deletions presenting
as b-thalassaemia trait and raised HbF were all of the
Southeast Asian (Vietnamese) deletion type. When these
deletions were co-inherited with classical b-thalassaemia
mutations in compound heterozygous states, the pheno-
types could be very variable.
Conclusions: In the Chinese population, there are only
relatively few types of deletions seen in the b-globin
cluster. MLPA is a fast and effective way of screening for
these deletions. Characterisation of these deletions allows
the development of simpler and more specific PCR-based
tests for routine diagnostic use. Accurate prediction of
phenotype is not always feasible. The molecular defects in
many cases of HPFH still await discovery.
Defects in the b-globin gene cluster at chromosome
11p15.4 cause thalassaemias, haemoglobinopathies
and fetal haemoglobin (HPFH). Deletions greater
than 1 kb are seen in deletional HPFH and most
db-thalassaemias. Deletions are distinctly uncom-
mon in b-thalassaemias, which are usually due to
single nucleotide substitutions or insertion/dele-
tion of a few nucleotides in the b-globin gene.1
Screening for larger deletions is technically diffi-
cult. Routine PCR-based techniques target only
known deletions, while direct nucleotide sequen-
cing of promotors, exons and exon-intron junc-
tions is not helpful in this setting as a normal allele
is present. Deletions can be screened by Southern
blotting, array comparative genomic hybridisation
(CGH), quantitative PCR, fluorescence in-situ
hybridisation with tiling probes and conventional
cytogenetics. However, these techniques all have
disadvantages of low resolution, high cost, poor
throughput, or complex test design and data
readout. Because of these limitations, the preva-
lence and nature of b-globin gene cluster deletions
in many populations remains uncharacterised. This
hinders the development of a comprehensive
diagnostic algorithm and the provision of genetic
counselling and prenatal diagnosis.
Multiplex ligation-dependent probe amplifica-
tion (MLPA) is a recently described method that
can detect mid-size deletions down to a few
hundred bases or single exon level.2 Each probe
consists of two oligonucleotides that bind adjacent
to each other at the target sequence. A ligation
reaction takes place and all intact probes are
amplified in a PCR using one single set of labelled
primers as all probes have the same primer
recognition ends. Amplification products differ in
size, which can be separated by electrophoresis
using a standard sequencer. The peak height/area
of a probe represents the amount of amplification
product, which is in turn proportional to the copy
number of target sequence recognised by the probe
in the sample. This technique is fast and reliable
and it can be applied to many hereditary and
acquired diseases caused by gene dosage changes.3
We used a commercial MLPA kit to screen a group
of Chinese patients suspected to have deletions in
the b-globin gene cluster. Deletions detected were
further characterised and correlated with pheno-
typic data. The study results provide information
on the prevalence of these deletions in the Chinese
population and thus facilitate the development of
simple and specific testing protocols.
METHODS
Subjects, phenotyping and globin genotyping
A total of 106 Chinese subjects suspected to have
deletions in the b-globin gene cluster were identi-
fied in our records from 1998 to 2008; 102 were
archive clinical samples sent for globin phenotyp-
ing and genotyping, and 4 patients were recruited
from an ongoing genetic association project.
Clinical and haematological data, including blood
counts and haemoglobin (Hb) study results, were
retrieved. HbA2 and HbF levels were assayed using
cation exchange high performance liquid chroma-
tography (1998 to June 2003, Variant; July 2003–
06, Variant II, BioRad, Hercules, California, USA).
DNA was extracted from peripheral blood samples
collected in EDTA using standard phenol/chloro-
form method. Routine a-globin genotyping
(screening for 22SEA, 2a3.7 and 2a4.2), b-globin
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genotyping (screening for deletion of CTTT in codons 41/42,
IVSII-nt 654 (CRT), nt -28 (ARG), codon 17 (ART), codon 43
(GRT) and codons 71/72 (+A)), detection of anti-3.7 and anti-
4.2 a globin gene triplication, and direct nucleotide sequencing
of a- and b-globin gene were performed as previously described
at diagnosis in all 106 subjects.4 5 A gap PCR for was set up in
our laboratory to detect Chinese (Acdb)0 thalassaemia since 2003
and those cases were not included. No routine molecular test for
HPFH was established before this study.
There were 46 men and 60 women, aged 4 months to 82
years. They were categorised into seven groups according to
phenotype and routine globin genotyping results (table 1).
In group IV, subjects had raised HbA2 suggestive of b-
thalassaemia trait but their HbF with significantly raised
(.5%). No b-globin gene mutation was detectable in this
group. In group V, subjects harboured a common heterozygous
b-globin gene mutation. A concomitant HPFH trait was
suspected because of raised HbF. In group VI, patients had a
b-thalassaemia intermedia or major phenotype, but a b-globin
gene mutation was only found in one of the parents, which was
inherited by the patients. None of the patients had a triplicated
a-globin gene configuration that could have modified their
clinical phenotype. We also included in this study a group of
patients with b-thalassaemia intermedia or major phenotype
(group VII). Only one common b-globin gene mutation was
detected. As no family study was performed, homozygosity was
presumed but not confirmed. A deletion of the other b-allele
could not be excluded.
Twenty-six archive normal DNA samples with normal red
cell indices and haemoglobin study results, and one archive
sample with known Chinese (Acdb)0 thalassaemia deletion were
used as negative and positive controls respectively for validation
of the MLPA kit.
Multiplex ligation-dependent probe amplification
Probes and reaction mixture for ligation and PCR were
purchased from MRC-Holland (SALSA MLPA kit P102 HBB,
MRC-Holland, Amsterdam, the Netherlands). Twenty-five
probes spanning a 68.7 kb region of the b-globin gene cluster
from 59 of the locus control region to 39 of the b-globin gene
were used. HS1–4 of the b-locus control region and all coding
genes (HBE1, HBG2, HBG1, HBD, HBB) were targeted. Four
DNA quantity control probes were included to safeguard
adequacy of test DNA, and another ligation-dependent probe
targeted at chromosome 2q14 was used to control for successful
ligation reaction. Fourteen other control probes targeting
different chromosomal sites other than 11p15.4 were present
in the probemix for result normalisation in each sample. The
SALSA MLPA P102 HBB probemix was designed by Helena
Duarte and Jan Schouten at MRC-Holland. A 200 ng aliquot of
sample DNA was used for each subject. Tests were performed
according to the manufacturer’s instructions using a standard
thermocycler (GeneAmp PCR System 9700, Applied Biosystems,
Foster City, California, USA). Amplification products were
separated by electrophoresis in an ABI-3130XL Genetic Analyzer
(Applied Biosystems) and results analysed by GeneMapper v3.7
(Applied Biosystems). A normal control sample was run in every
batch of patient samples.
MLPA data analysis
Data from GeneMapper were exported to a web-based program
for analysis (Coffalyser MLPA DAT v5.4, MRC-Holland).
Global normalisation was used, where all peak areas were
normalised by dividing each peak area by the combined peak
area of all peaks in a particular sample. From the 26 normal
samples, the mean and SD of the normalised peak area for each
probe was calculated. Deletion of a probe recognition sequence
in a patient sample was defined as a normalised peak area below
3 SD of the mean normalised peak area for that probe in the
normal controls. Heterozygous deletion (copy number of one)
resulted in a 35–50% reduction of normalised peak area of a
probe. Homozygous deletion (zero copy) was seen as complete
absence of a peak.
Characterisation of deletions detected by MLPA
The extent of deletions detected by MLPA was compared to
known b-globin gene cluster deletions reported in Southeast
Asians. Gap PCR was performed to screen for candidate
deletions using the respective flanking primers (table 2).
Details of reaction conditions are available as supplementary
data on the website.
RESULTS
Performance of MLPA
No loss of probe amplification signal (no deletion) was detected
in any of the 26 normal control samples. Deletion with an
extent consistent with Chinese (Acdb)0 thalassaemia was
detected in the positive control sample previously confirmed
to have this deletion. The DNA quantity controls and ligation-
Table 1 Classification of 106 patients by phenotype and routine globin genotyping results




I b-thalassaemia trait, no b-globin gene mutation detected 4 60.0–83.5 19.6–27.8 4.0–5.8 0.3–1.0 0
II db-thalassaemia trait, no b-globin gene mutation detected 8 59.6–79.8* 17.5–27.5 2.3–2.8 6.8–21.8 4
III HPFH trait, no b-globin gene mutation detected 10 63.1–112.2{ 20.4–38.0{ 1.0–3.5 5.2–64.5 1
IV b-thalassaemia trait with raised HbF, no b-globin gene
mutation detected
9 58.3–80.6 19.2–27.8 3.7–6.0 6.4–45.3 5
V b-thalassaemia trait with raised HbF, one common b-
globin gene mutation detected
16 58.3–75.3 17.8–26.7 1.6–6.6 6.9–90.0 0
VI b-thalassaemia intermedia/major, b-globin gene mutation
detected in only one parent
28 50.4–97.4{ 12.4–31.2{ 0.3–7.5 0.8–99.5{ 5
VII b-thalassaemia intermedia/major, presumably
homozygous, no family study
31 63.7–91.2{ 19.4–29.7{ 0.0–8.1 0.3–90.0{ 2
*Patient had concomitant iron deficiency anaemia.
{Two patients with low MCV had concomitant a-thalassaemia trait (22SEA deletion); 1 patient with normal MCV and low MCH had heterozygous Hb Constant Spring mutation.
{Most patients had received red cell transfusion.
MCH, mean corpuscular haemoglobin; MCV, mean corpuscular volume; MLPA, multiplex ligation-dependent probe amplification.
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dependent control confirmed sufficient DNA and successful
ligation and amplification in all test batches. In five patient
samples, reduced peak areas were seen in several isolated single
probes. Probes involved were non-random (exon 1 of d-globin
gene and exons 2 and 3 of b-globin gene). Polymorphism or
genuine deletion of the probe binding sites was initially
suspected. Direct DNA sequencing of these sites using primers
derived from the recognition sequences of flanking MLPA
probes showed no evidence of polymorphism or deletion in any
of the five patients (data not shown). Testing was repeated
using a new version of the MLPA kit (SALSA MLPA kit P102-B1
HBB, MRC-Holland) in which the three implicated probes were
redesigned. No loss of probe signal was observed, suggesting
that the inconsistent amplification of the three probes in the
original kit was likely due to suboptimal probe design.
Deletion detected by MLPA
A total of 17 heterozygous deletions were detected in 17
patients, accounting for 16% of 106 subjects studied. All
deletions were characterised by gap PCR using primers for
known b-globin gene cluster deletions reported in Southeast
Asians. Figure 1 shows the extent of the three types of deletion
found, in relation to the main regulatory elements at the b-
globin gene cluster. Table 3 shows clinical phenotype, haema-
tological data and the final b-globin cluster genotype of these 17
patients.
The commonest type was Chinese (Acdb)0 thalassaemia9
(n = 8), followed by Southeast Asian (Vietnamese) deletion10
(n = 7) and Thai (Acdb)0 thalassaemia (HPFH-6)8 (n = 2).
Deletions were mostly found in group II (db-thalassaemia trait,
4/8), group IV (b-thalassaemia trait with raised HbF, 5/9) and
group VI (b-thalassaemia intermedia/major with b-globin gene
mutation detected only in one parent, 5/28). Together they
accounted for 14 of 17 deletions detected. Deletions were
distinctly uncommon in group I (b-thalassaemia trait, 0/4),
group III (HPFH trait, 1/10) and group V (heterozygous b-
globin gene mutation with raised HbF, 0/16) (table 2).
In the heterozygous state (groups I to V), the types of
deletion detected within each group were homogeneous. All
four deletions found in group II (db-thalassaemia trait) were
Chinese (Acdb)0 thalassaemia. All five deletions found in group
IV (b-thalassaemia trait with raised HbF) were Southeast Asian
(Vietnamese) deletion. The single case of deletional HPFH
found in group III was Thai (Acdb)0 thalassaemia (HPFH-6). On
the other hand, different types of deletions were seen in patients
with b-thalassaemia intermedia/major in groups VI and VII,
where the deletions occurred in the compound heterozygous
state with a co-existing b+ or b0 mutation.
Of note, 2 of 31 b-thalassaemia intermedia/major patients in
group VII, who were previously diagnosed to have homozygous
b-globin gene mutation using routine globin genotyping
methods, were found to harbour a b-globin gene cluster
deletion.
DISCUSSION
This is the largest study reporting to date on globin gene
deletion in thalassaemia patients using MLPA as a screening
tool. Excluding group VII (patients presumably labelled as
homozygous for common b-thalassaemia mutations without
family study) where the pre-test probability for deletion is the
lowest, the deletion detection rate in our cohort is only 20%
(15/75). A further 9 patients with db-thalassaemia of the
Chinese (Acdb)0 type were detected in our laboratory by gap
PCR since 2003 during the study period. Inclusion of these 9
cases in our cohort would only have increased the prevalence to
28.5% (24/84). This is still substantially lower than the 61%
reported in a previous Dutch study using the same method,11
although sample selection criteria are different. These findings
suggest that there may be major differences in the prevalence of
b-globin cluster deletion among different ethnic groups.
Within our Chinese cohort, relatively few types of deletion
are present in defined phenotypic groups. Chinese (Acdb)0
thalassaemia is the only deletion detected in db-thalassaemia.
In the heterozygous state, Southeast Asian (Vietnamese)
Table 2 Primer sequences and references
PCR primer Primer sequence Reference




For Southeast Asian (Vietnamese) deletion
FH1 59-TGGTATCTGCAGCAGTTGCC-39 7
FH4 59-AGCCTCATGGTAGCAGAATC-39
For Thai (Acdb)0 thalassaemia (HPFH-6)
p1 59-CTCTATAGGACAGGACTCCTCAGA-39 8, with modification
p2 59-AGAGCCTTAGGTATTAACGTTGGAGG-39
Figure 1 Schematic diagram of extent
of the three deletions identified.8–10 LCR,
locus control region; Ikaros TFBS, Ikaros
transcription factor binding site implicated
in cb-globin gene switching; 39HS-1,
39 DNAase hypersensitivity region-1 c-
silencing element; enhancer, 39 erythroid-
specific enhancer element.
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deletion characteristically gives rise to an otherwise typical b-
thalassaemia trait phenotype with microcytosis and increased
HbA2, albeit with a significantly raised HbF level as well. This
unique phenotype is predictable from its extent of deletion,
which includes the b-globin gene and the 39HS-1 c-silencing
element, but leaves the d-globin gene and the further 39
erythroid-specific enhancer element intact (fig 1). If the
presence of a common b-thalassaemia mutation has been
excluded, Southeast Asian (Vietnamese) deletion should be
considered when patients present with this particular pheno-
type. Only one form of deletional HPFH is seen—Thai (Acdb)0
thalassaemia (HPFH-6), which spares the 39 erythroid-specific
enhancer element (fig 1). Knowledge of this homogeneity of b-
globin cluster deletions in Chinese and their characteristic
phenotypes will facilitate the set-up of a fast, efficient and
comprehensive PCR-based protocol for molecular diagnosis of b-
globin cluster disorders.
The two patients who are compound heterozygous for
Southeast Asian (Vietnamese) deletion and b0-thalassaemia
mutation present as b-thalassaemia intermedia (table 3). This
argues against it being a deletional HPFH defect as previously
suggested,12 but is more akin to a b-thalassaemia phenotype
with raised HbF as is seen in all five heterozygous subjects in the
present study. However, the phenotypes of compound hetero-
zygotes of Chinese (Acdb)0 or Thai (Acdb)0 defect with common
b0 thalassaemia mutation are less predictable. One of the two
patients with identical bIVS2 654(C.T)/bChinese (Acdb)0 genotype
presents as b-thalassaemia major while the other shows only
intermedia severity. The patient who is compound heterozy-
gous for b43(GAG.TAG)/bThai (Acdb)0 has thalassaemia major which is
much more severe than one will expect from a b0/bHPFH
genotype. It is certain that other unidentified modifiers of
disease phenotype, such as separate HPFH traits or rarer forms
of a-gene duplication, exist to account for the observed
phenotypic heterogeneity. Further studies on these complex
interactions will not only broaden our knowledge of thalassae-
mia pathogenesis but can greatly facilitate genetic counselling.
Deletions are not detectable in many thalassaemic subjects in
our patient cohort. The underlying molecular defects leading to
thalassaemia remain elusive. Non-deletional mutations in the
regulatory regions in b-globin cluster can be targets for further
investigation, such as the b-locus control region, the Ikaros
transcription factor binding site immediately upstream of d-globin
gene which is implicated in cb-globin gene switching,13 the 39HS-1
regulatory sequence for c-silencing14 and the further 39 erythroid-
specific enhancer element.15 We have excluded common tripli-
cated a-globin gene configurations by multiplex PCR, although
rarer forms of a-globin gene duplication causing an intermedia
phenotype in some b-thalassaemia heterozygotes are still
possible.16 The very low detection rate in patients suspected to
harbour deletional HPFH is unexpected, as many of them have
significantly raised HbF above 10% to even 50%. Further studies
to look for non-deletional types of HPFH mutations within the b-
globin cluster such as c-promoter mutations are indicated. Other
quantitative trait loci for HbF expression, including chromosome
6q23 and 2p15 region have also been shown in various
populations, including Chinese.17 18
Our study clearly shows a role for MLPA in deletion screening
in the b-globin cluster. The technique is fast and easy to perform,
requiring only standard instruments in a routine molecular
diagnostic laboratory. Results analysis is simple. It is relatively
inexpensive when compared to other techniques such as Southern
blotting, array CGH or quantitative PCR. However, the potential
pitfalls must be borne in mind. Theoretically, small deletions of
unknown regulatory regions in the b-globin cluster not targeted
by the MLPA probes can be missed, as consecutive probes are not
continuous or overlapping. Loss of isolated single probes must
therefore be interpreted with caution. One has to exclude
polymorphism at binding sites of probes and use alternative
methods to confirm any suspected small deletions.
Table 3 Clinical phenotype, haematological data and final globin genotype of 17 patients with deletions detected by multiplex ligation-dependent
probe amplification
Clinical phenotype b-genotype a-genotype Hb (g/l) MCV (fl) MCH (pg) HbA2 (%) HbF (%)
db-thalassaemia trait (n = 4) bA/bChinese (Acdb)0 aa/22SEA 146 70.6 23.9 2.5 14.9
bA/bChinese (Acdb)0 aa/22SEA 127 69.5 23.1 2.8 10.0
bA/bChinese (Acdb)0 aa/22SEA 109 68.2 21.6 2.7 10.4
bA/bChinese (Acdb)0 aa/aa 85* 59.6* 17.5 2.6* 9.4*
HPFH (n = 1) bA/bThai (Acdb)0 aa/aa 137 84.3 28.0 2.0 28.3
Raised HbA2 and HbF (n = 5) b
A/bSoutheast Asian (Vietnamese) aa/aa 131 80.6 25.8 4.5 21.3
bA/bSoutheast Asian (Vietnamese) aa/aa 126 78.9 23.3 5.3 11.6
bA/bSoutheast Asian (Vietnamese) aa/aa 125 73.5 24.2 4.7 23.0
bA/bSoutheast Asian (Vietnamese) aa/aa 123 79.3 26.4 3.9 26.4
bA/bSoutheast Asian (Vietnamese) aa/aa 115 72.6 25.3 3.7 21.9
b-thalassaemia intermedia (n = 4) bIVS2 654(C.T)/bChinese (Acdb)0 aa/aa 117{ 71.1{ 22.9{ 3.7{ 24.0{
bIVS2 654(C.T)/bSoutheast Asian (Vietnamese) aa/aa 113 63.7 21.0 3.0 95.7
b41/42(2CTTT)/bSoutheast Asian (Vietnamese) aa/aa 104 63.4 20.7 3.8 95.7
b228(A.G)/bChinese (Acdb)0 aa/aa 77 78.9 24.0 2.3 84.8
b-thalassaemia major (n = 3) b41/42(2CTTT)/bChinese (Acdb)0 aa/aa 78{ 72.9{ 22.3{ 2.6{ 32.0{
bIVS2 654(C.T)/bChinese (Acdb)0 aa/aa 70 75.1 24.1 0.3 99.5
b43(GAG.TAG)/bThai (Acdb)0 aa/aa 78{ 78.1{ 26.8{ 3.0{ 14.0{
*Concomitant iron deficiency anaemia documented.
{Patients receiving regular red cell transfusion therapy.
MCH, mean corpuscular haemoglobin; MCV, mean corpuscular volume.
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In conclusion, using MLPA as a screening tool, relatively few
types of deletions are seen in the b-globin gene cluster in
Chinese. Characterisation of these deletions allows the devel-
opment of simpler and more specific PCR-based tests for their
detection, a strategy that has been successfully employed for
detection of common a-globin gene deletions using a multiplex
gap–PCR approach. However, accurate genotype–phenotype
correlation is not always feasible. Moreover, the molecular
defects in many cases of HPFH still await discovery. Whether
these observations can be generalised depends on results of
similar large scale studies in other Chinese populations.
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Take-home messages
c Large deletions in the b-globin gene cluster are relatively
uncommon in Chinese, particularly in the group of hereditary
persistence of fetal haemoglobin.
c A narrow spectrum of deletions is observed, with each
deletion showing a characteristic phenotype.
c However, an accurate genotype–phenotype prediction is not
always possible in the compound heterozygous states.
c Multiplex ligation-dependent probe amplification is a good
screening method for unknown b-globin gene cluster
deletions.
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